CUNY Halts Investigation of Alzheimer’s Researcher newsfragment


The Town College of Pristine York is pausing its investigation into a college member, an Alzheimer’s researcher accused of misconduct, the college said in a statement on Friday.

Research through the neuroscientist, Hoau-Yan Wang, underpin an Alzheimer’s drug in complex medical trials. The drug, simufilam, is made through Cassava Sciences, a pharmaceutical corporate primarily based in Texas. Dr. Wang regularly collaborated with Lindsay H. Burns, the corporate’s important scientist.

“Because questions regarding the confidentiality and integrity of this investigation have been raised, CUNY will stay the underlying inquiry into the allegations regarding Dr. Wang’s research until such time as the University completes a comprehensive investigation of the process,” the college stated.

Dr. Wang didn’t reply to a request for remark.

“Since September 2021, Cassava Sciences has been waiting for a reliable and credible investigation from CUNY,” Remi Barbier, Cassava’s founder and important government, stated in an e-mail. “We’re still waiting.”

From the beginning, some scientists have been skeptical of simufilam’s purported form of motion and nearest of Cassava’s experiences of enhancements amongst its medical trial individuals. Following accusations in 2021 that Dr. Wang and Cassava can have manipulated information, the Securities and Change Fee and the Nationwide Institutes of Condition started investigating the analysis.

A committee convened through CUNY additionally started an investigation into Dr. Wang’s paintings and his lab’s funds over twenty years.

On Oct. 12, the magazine Science made public a draft of the committee’s document, which concluded that Dr. Wang was once “reckless” in his failure to stock or grant untouched information, an offense that “amounts to significant research misconduct.” (The investigators additionally concluded that Dr. Burns was once answerable for mistakes in one of the crucial papers.)

CUNY declined to remark at the report on the while however stated it could officially drop the document this occasion. Since later, critics have wondered the objectivity of the investigators and the veracity in their descriptions of Dr. Wang’s responses to the inquiry.

On Friday, the college declined to touch upon those allegations past its authentic observation.

“Consistent with its policy, CUNY will not comment on the accuracy of the investigation referenced in the articles because no final action as to this investigation has been taken,” the observation stated.

“CUNY is committed to ensuring that its investigative processes are held to the highest procedural and ethical standards and that the fairness of the proceedings is preserved for all parties,” the college added. “To that end, any finding regarding allegations of research misconduct must be reliable and credible.”


Leave a Reply

Your email address will not be published. Required fields are marked *